The Oncology Institute Inc. (TOI) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for The Oncology Institute Inc. (TOI:NASDAQ), powered by AI.

Current Price
$5.10
Sector
Healthcare
What is the The Oncology Institute Inc. stock price forecast?

The Oncology Institute Inc. is currently trading at $5.10. View real-time AI analysis on Alpha Lenz.

What is The Oncology Institute Inc. insider trading activity?

View the latest insider trading data for The Oncology Institute Inc. on Alpha Lenz.

What is The Oncology Institute Inc.'s P/E ratio?

View The Oncology Institute Inc.'s valuation metrics on Alpha Lenz.

The Oncology Institute Inc.

NASDAQ · TOI
$5.10-0.08(-1.54%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about The Oncology Institute Inc.'s future dividend policy...
Alpha Chat Insight

The Oncology Institute Inc.'s ROE is 999.2%. Explore profitability and growth together.

Ask for details

Company Overview

The Oncology Institute Inc. is a healthcare services provider deeply embedded in the oncology sector. It operates through a network of cancer treatment centers across the United States, offering comprehensive and integrated care for cancer patients. The Institute focuses on delivering high-quality, value-based cancer care, utilizing cutting-edge technology, advanced therapies, and personalized treatment plans. Its structure supports both outpatient clinics and supportive care services, addressing the multifaceted needs of cancer patients. By emphasizing clinical excellence and innovation, The Oncology Institute aims to enhance patient outcomes while managing the cost of care. The Institute plays a critical role in the healthcare market by improving access to specialized oncology services in urban and rural communities alike. Through partnerships with healthcare providers, insurance networks, and the broader medical community, it contributes significantly to the advancement of cancer care, positioning itself as a pivotal player in the industry dedicated to addressing enduring oncological challenges.

CEODr. Daniel Virnich FACHE, M.B.A., M.D.
SectorHealthcare
IndustryMedical Care Facilities
Employees825

Company Statistics

FY 2025

Profile

N/AMarket Cap
$502.73MRevenue
0.00Shares Out
825Employees

Margins

15.20%Gross
-5.98%EBITDA
-7.18%Operating
-12.08%Pre-Tax
-12.06%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

25.81%Rev 3Yr
21.80%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-35.93%ROA
999.19%ROE
-29.32%ROIC

Financial Health

$33.56MCash & Cash Equivalents
$146.81MNet Debt
-1147.43%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

The Oncology Institute Inc. (ticker: TOI) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 825 employees.

The current price is $5.1 with a P/E ratio of -x and P/B of -x.

ROE is 999.19% and operating margin is -7.18%. Annual revenue is $503M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
The Oncology Institute Inc. (TOI) Stock Forecast 2026 $5.10 — Price, Financials & Analyst Targets | Alpha Lenz